ALCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Alcaine, and what generic alternatives are available?
Alcaine is a drug marketed by Alcon Labs Inc and is included in one NDA.
The generic ingredient in ALCAINE is proparacaine hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alcaine
A generic version of ALCAINE was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALCAINE?
- What are the global sales for ALCAINE?
- What is Average Wholesale Price for ALCAINE?
Summary for ALCAINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Clinical Trials: | 6 |
Patent Applications: | 3,999 |
DailyMed Link: | ALCAINE at DailyMed |
Recent Clinical Trials for ALCAINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Buddhist Tzu Chi General Hospital | Early Phase 1 |
William Beaumont Hospitals | Phase 4 |
Louisiana State University Health Sciences Center in New Orleans | Phase 4 |
Pharmacology for ALCAINE
Drug Class | Local Anesthetic |
Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for ALCAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | ALCAINE | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 080027-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |